Alder BioPharmaceuticals Regains Worldwide Rights To Clazakizumab

By: via Benzinga
Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a clinical-stage company developing antibody therapeutics, today announced that it has ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.